Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy)

Masahiro Tahara(The University of Osaka), Yuji Murata(The University of Osaka), Keiichi Tasaka(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Tetsu Matsuoka(The University of Osaka), Takeshi Yokoi(The University of Osaka)
Fertility and Sterility
April 1, 2000
10.1016/s0015-0282(99)00636-6
Cited by 45

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
A Physiological Role of Epidermal Growth Factor in Male Reproductive Function
|Science|1986|222
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212